Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120Nina D. Russell, Lawrence Corey, Barney S. Graham et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006Cited by 104
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adultsGeoffrey J. Gorse, Nina D. Russell, Lindsey R. Baden et al.|Vaccine|2007Cited by 59
Human immunodeficiency virus‐1 disease progression in hemophiliacsPaul Becherer, Gilbert White, M. Lynn Smiley et al.|American Journal of Hematology|1990Cited by 37
Transmission of human immunodeficiency virus to sexual partners of hemophiliacsM. Lynn Smiley, Dani P. Bolognesi, Campbell W. McMillan et al.|American Journal of Hematology|1988Cited by 36
Cellular Immune Response to Viral Peptides in Patients Exposed to HIVPAUL M. AHEARNE, Kent J. Weinhold, Thomas J. Matthews et al.|AIDS Research and Human Retroviruses|1988Cited by 35